| The economic burden of personality disorders in mental health care. DI Soeteman, LH Roijen, R Verheul, JJV Busschbach Journal of Clinical Psychiatry 69 (2), 259, 2008 | 444 | 2008 |
| The burden of disease in personality disorders: diagnosis-specific quality of life DI Soeteman, R Verheul, JJV Busschbach Journal of personality disorders 22 (3), 259-268, 2008 | 223 | 2008 |
| Risk-targeted lung cancer screening: a cost-effectiveness analysis V Kumar, JT Cohen, D van Klaveren, DI Soeteman, JB Wong, ... Annals of internal medicine 168 (3), 161-169, 2018 | 107 | 2018 |
| The burden of disease among adolescents with personality pathology: quality of life and costs DJ Feenstra, J Hutsebaut, EMP Laurenssen, R Verheul, JJV Busschbach, ... Journal of personality disorders 26 (4), 593-604, 2012 | 87 | 2012 |
| Bayesian methods for calibrating health policy models: a tutorial NA Menzies, DI Soeteman, A Pandya, JJ Kim Pharmacoeconomics 35 (6), 613-624, 2017 | 70 | 2017 |
| Cost-effectiveness of psychotherapy for cluster B personality disorders DI Soeteman, R Verheul, J Delimon, AMMA Meerman, E van den Eijnden, ... The British Journal of Psychiatry 196 (5), 396-403, 2010 | 60 | 2010 |
| Strengthening the status of psychotherapy for personality disorders: an integrated perspective on effects and costs A Bartak, DI Soeteman, R Verheul, JJV Busschbach The Canadian Journal of Psychiatry 52 (12), 803-810, 2007 | 51 | 2007 |
| Cost-effectiveness of psychotherapy for cluster C personality disorders: a decision-analytic model in the Netherlands DI Soeteman, R Verheul, AMMA Meerman, U Ziegler, BV Rossum, ... The Journal of clinical psychiatry 72 (1), 51-59, 2010 | 37 | 2010 |
| Cost-Effectiveness of Esketamine Nasal Spray for Patients With Treatment-Resistant Depression in the United States EL Ross, DI Soeteman Psychiatric Services 71 (10), 988-997, 2020 | 30 | 2020 |
| Gender disparity in critical care publications: a novel Female First Author Index S Chary, K Amrein, DI Soeteman, S Mehta, KB Christopher Annals of Intensive Care 11 (1), 103, 2021 | 26 | 2021 |
| Cost-effectiveness of colorectal cancer screening in Ukraine N Melnitchouk, DI Soeteman, JS Davids, A Fields, J Cohen, F Noubary, ... Cost Effectiveness and Resource Allocation 16 (1), 1-9, 2018 | 24 | 2018 |
| onlineDeCISion. org: a web-based decision aid for DCIS treatment EM Ozanne, KH Schneider, D Soeteman, N Stout, D Schrag, M Fordis, ... Breast cancer research and treatment 154 (1), 181-190, 2015 | 23 | 2015 |
| Modeling the effectiveness of initial management strategies for ductal carcinoma in situ DI Soeteman, NK Stout, EM Ozanne, C Greenberg, MJ Hassett, D Schrag, ... JNCI: Journal of the National Cancer Institute 105 (11), 774-781, 2013 | 21 | 2013 |
| Assessment of the burden of disease among inpatients in specialized units that provide psychotherapy DI Soeteman, R Timman, RW Trijsburg, R Verheul, JJV Busschbach Psychiatric services 56 (9), 1153-1155, 2005 | 21 | 2005 |
| Cost-Effectiveness of Routine Screening for Autoimmune Encephalitis in Patients With First-Episode Psychosis in the United States. EL Ross, JE Becker, JJ Linnoila, DI Soeteman The Journal of Clinical Psychiatry 82 (1), 2020 | 15 | 2020 |
| Cost-effective psychotherapy for personality disorders in the Netherlands: The value of further research and active implementation DI Soeteman, JJV Busschbach, R Verheul, T Hoomans, JJ Kim Value in Health 14 (2), 229-239, 2011 | 14 | 2011 |
| Can Pay-for Performance Incentive Levels be Determined Using a Cost-Effectiveness Framework? A Pandya, DI Soeteman, A Gupta, H Kamel, AI Mushlin, MB Rosenthal Circulation: Cardiovascular Quality and Outcomes 13 (7), e006492, 2020 | 10 | 2020 |
| Would a large tPA trial for those 4.5 to 6.0 hours from stroke onset be good value for information? DI Soeteman, NA Menzies, A Pandya Value in Health 20 (7), 894-901, 2017 | 10 | 2017 |
| Modeling the risks and benefits of depression treatment for children and young adults DI Soeteman, M Miller, JJ Kim Value in health 15 (5), 724-729, 2012 | 9 | 2012 |
| Cost–effectiveness of psychotherapy for personality disorders: treatment recommendations and implementation DI Soeteman, JJ Kim Expert review of pharmacoeconomics & outcomes research 13 (1), 73-81, 2013 | 8 | 2013 |
